Compare STXS & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STXS | HGLB |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.1M | 207.7M |
| IPO Year | 2004 | N/A |
| Metric | STXS | HGLB |
|---|---|---|
| Price | $2.43 | $10.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 695.3K | 91.8K |
| Earning Date | 11-11-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,075,000.00 | N/A |
| Revenue This Year | $30.98 | N/A |
| Revenue Next Year | $49.86 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.62 | N/A |
| 52 Week Low | $1.54 | $6.42 |
| 52 Week High | $3.59 | $9.45 |
| Indicator | STXS | HGLB |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 58.10 |
| Support Level | $2.20 | $9.04 |
| Resistance Level | $2.50 | $10.37 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 44.37 | 74.22 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.